{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:50:51Z","timestamp":1778025051194,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,7,8]],"date-time":"2012-07-08T00:00:00Z","timestamp":1341705600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s12035-012-8295-4","type":"journal-article","created":{"date-parts":[[2012,7,7]],"date-time":"2012-07-07T08:22:55Z","timestamp":1341649375000},"page":"475-486","source":"Crossref","is-referenced-by-count":137,"title":["Tauroursodeoxycholic Acid Prevents MPTP-Induced Dopaminergic Cell Death in a Mouse Model of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"46","author":[{"given":"M.","family":"Castro-Caldas","sequence":"first","affiliation":[]},{"given":"A. Neves","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"E.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"C. J.","family":"Henderson","sequence":"additional","affiliation":[]},{"given":"C. R.","family":"Wolf","sequence":"additional","affiliation":[]},{"given":"C. M. P.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"M. J.","family":"Gama","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,7,8]]},"reference":[{"key":"8295_CR1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909","journal-title":"Neuron"},{"issue":"Suppl 1","key":"8295_CR2","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1016\/S1353-8020(11)70057-8","volume":"18","author":"V Jackson-Lewis","year":"2012","unstructured":"Jackson-Lewis V, Blesa J, Przedborski S (2012) Animal models of Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S183\u2013S185","journal-title":"Parkinsonism Relat Disord"},{"issue":"5646","key":"8295_CR3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","volume":"302","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson\u2019s disease. Science 302(5646):819\u2013822","journal-title":"Science"},{"issue":"5","key":"8295_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cnr.2006.09.006","volume":"6","author":"RL Mosley","year":"2006","unstructured":"Mosley RL, Benner EJ, Kadiu I, Thomas M, Boska MD, Hasan K, Laurie C, Gendelman HE (2006) Neuroinflammation, oxidative stress and the pathogenesis of Parkinson\u2019s disease. Clin Neurosci Res 6(5):261\u2013281","journal-title":"Clin Neurosci Res"},{"issue":"2","key":"8295_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1471-4159.2008.05604.x","volume":"107","author":"M Vila","year":"2008","unstructured":"Vila M, Ramonet D, Perier C (2008) Mitochondrial alterations in Parkinson\u2019s disease: new clues. J Neurochem 107(2):317\u2013328","journal-title":"J Neurochem"},{"issue":"1","key":"8295_CR6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11064-008-9656-2","volume":"34","author":"RL Miller","year":"2009","unstructured":"Miller RL, James-Kracke M, Sun GY, Sun AY (2009) Oxidative and inflammatory pathways in Parkinson\u2019s disease. Neurochem Res 34(1):55\u201365","journal-title":"Neurochem Res"},{"key":"8295_CR7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1471-4159.1991.tb02134.x","volume":"57","author":"P Chan","year":"1991","unstructured":"Chan P, DeLanney LE, Irwin I, Langston JW, Di Monte D (1991) Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J Neurochem 57:348\u2013351","journal-title":"J Neurochem"},{"issue":"5","key":"8295_CR8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0892-0362(02)00213-1","volume":"24","author":"A Nicotra","year":"2002","unstructured":"Nicotra A, Parvez S (2002) Apoptotic molecules and MPTP-induced cell death. Neurotoxicol Teratol 24(5):599\u2013605","journal-title":"Neurotoxicol Teratol"},{"issue":"1","key":"8295_CR9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1568007053005145","volume":"4","author":"CY Kuan","year":"2005","unstructured":"Kuan CY, Burke RE (2005) Targeting the JNK signaling pathway for stroke and Parkinson\u2019s diseases therapy. Curr Drug Targets CNS Neurol Disord 4(1):63\u201367","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"4-5","key":"8295_CR10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/1521654031000121666","volume":"55","author":"J Peng","year":"2003","unstructured":"Peng J, Andersen JK (2003) The role of c-Jun N-terminal kinase (JNK) in Parkinson\u2019s disease. IUBMB Life 55(4-5):267\u2013271","journal-title":"IUBMB Life"},{"issue":"2","key":"8295_CR11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1073\/pnas.0307453101","volume":"101","author":"S Hunot","year":"2004","unstructured":"Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S, Rakic P, Flavell RA (2004) JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 101(2):665\u2013670","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"8295_CR12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0006-8993(97)00862-7","volume":"771","author":"K Nishi","year":"1997","unstructured":"Nishi K (1997) Expression of c-Jun in dopaminergic neurons of the substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Brain Res 771(1):133\u2013141","journal-title":"Brain Res"},{"issue":"3","key":"8295_CR13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1046\/j.1471-4159.2000.0751200.x","volume":"75","author":"MS Saporito","year":"2000","unstructured":"Saporito MS, Thomas BA, Scott RW (2000) MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J Neurochem 75(3):1200\u20131208","journal-title":"J Neurochem"},{"key":"8295_CR14","doi-asserted-by":"crossref","unstructured":"Castro-Caldas M, Neves Carvalho A, Rodrigues E, Henderson C, Wolf CR, Gama MJ (2012) Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway. Mol Neurobiol 45(3):466\u2013477","DOI":"10.1007\/s12035-012-8266-9"},{"issue":"2","key":"8295_CR15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neures.2003.10.012","volume":"48","author":"W Wang","year":"2004","unstructured":"Wang W, Shi L, Xie Y, Ma C, Li W, Su X, Huang S, Chen R, Zhu Z, Mao Z, Han Y, Li M (2004) SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson\u2019s disease. Neurosci Res 48(2):195\u2013202","journal-title":"Neurosci Res"},{"issue":"2","key":"8295_CR16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/labinvest.2009.124","volume":"90","author":"J Pan","year":"2010","unstructured":"Pan J, Qian J, Zhang Y, Ma J, Wang G, Xiao Q, Chen S, Ding J (2010) Small peptide inhibitor of JNKs protects against MPTP-induced nigral dopaminergic injury via inhibiting the JNK-signaling pathway. Lab Invest 90(2):156\u2013167","journal-title":"Lab Invest"},{"issue":"1","key":"8295_CR17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","volume":"35","author":"KN Lazaridis","year":"2001","unstructured":"Lazaridis KN, Gores GJ, Lindor KD (2001) Ursodeoxycholic acid \u2018mechanisms of action and clinical use in hepatobiliary disorders\u2019. J Hepatol 35(1):134\u2013146","journal-title":"J Hepatol"},{"issue":"3","key":"8295_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03401914","volume":"4","author":"CM Rodrigues","year":"1998","unstructured":"Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ (1998) Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 4(3):165\u2013178","journal-title":"Mol Med"},{"issue":"3","key":"8295_CR19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1471-4159.2004.02517.x","volume":"90","author":"RM Ramalho","year":"2004","unstructured":"Ramalho RM, Ribeiro PS, Sol\u00e1 S, Castro RE, Steer CJ, Rodrigues CM (2004) Inhibition of the E2F-1\/p53\/Bax pathway by tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells. J Neurochem 90(3):567\u2013575","journal-title":"J Neurochem"},{"issue":"1","key":"8295_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-2011-100395","volume":"27","author":"RJ Viana","year":"2011","unstructured":"Viana RJ, Steer CJ, Rodrigues CM (2011) Amyloid-\u03b2 peptide-induced secretion of endoplasmic reticulum chaperone glycoprotein GRP94. J Alzheimers Dis 27(1):61\u201373","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"8295_CR21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3233\/JAD-2010-100909","volume":"22","author":"RJ Viana","year":"2010","unstructured":"Viana RJ, Ramalho RM, Nunes AF, Steer CJ, Rodrigues CM (2010) Modulation of amyloid-\u03b2 peptide-induced toxicity through inhibition of JNK nuclear localization and caspase-2 activation. J Alzheimers Dis 22(2):557\u2013568","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"8295_CR22","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","volume":"101","author":"CM Rodrigues","year":"1998","unstructured":"Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ (1998) A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 101(12):2790\u20132799","journal-title":"J Clin Invest"},{"issue":"9","key":"8295_CR23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.cdd.4400560","volume":"6","author":"CM Rodrigues","year":"1999","unstructured":"Rodrigues CM, Ma X, Linehan-Stieers C, Fan G, Kren BT, Steer CJ (1999) Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ 6(9):842\u2013854","journal-title":"Cell Death Differ"},{"issue":"2","key":"8295_CR24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/exnr.2001.7755","volume":"171","author":"CD Keene","year":"2001","unstructured":"Keene CD, Rodrigues CM, Eich T, Linehan-Stieers C, Abt A, Kren BT, Steer CJ, Low WC (2001) A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington\u2019s disease. Exp Neurol 171(2):351\u2013360","journal-title":"Exp Neurol"},{"issue":"16","key":"8295_CR25","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1073\/pnas.162362299","volume":"99","author":"CD Keene","year":"2002","unstructured":"Keene CD, Rodrigues CM, Eich T, Chhabra MS, Steer CJ, Low WC (2002) Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington\u2019s disease. Proc Natl Acad Sci USA 99(16):10671\u201310676","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9-12","key":"8295_CR26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2119\/2003-00042.Rodrigues","volume":"9","author":"S Sol\u00e1","year":"2003","unstructured":"Sol\u00e1 S, Castro RE, Laires PA, Steer CJ, Rodrigues CM (2003) Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway. Mol Med 9(9-12):226\u2013234","journal-title":"Mol Med"},{"issue":"5","key":"8295_CR27","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1471-4159.2006.04007.x","volume":"98","author":"RM Ramalho","year":"2006","unstructured":"Ramalho RM, Borralho PM, Castro RE, Sol\u00e1 S, Steer CJ, Rodrigues CM (2006) Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer\u2019s disease mutant neuroblastoma cells. J Neurochem 98(5):1610\u20131618","journal-title":"J Neurochem"},{"issue":"10","key":"8295_CR28","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1210\/me.2006-0063","volume":"20","author":"S Sol\u00e1","year":"2006","unstructured":"Sol\u00e1 S, Amaral JD, Borralho PM, Ramalho RM, Castro RE, Aranha MM, Steer CJ, Rodrigues CM (2006) Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid beta-peptide-induced apoptosis. Mol Endocrinol 20(10):2292\u20132303","journal-title":"Mol Endocrinol"},{"issue":"6","key":"8295_CR29","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s00018-009-8746-x","volume":"66","author":"RJ Viana","year":"2009","unstructured":"Viana RJ, Nunes AF, Castro RE, Ramalho RM, Meyerson J, Fossati S, Ghiso J, Rostagno A, Rodrigues CM (2009) Tauroursodeoxycholic acid prevents E22Q Alzheimer\u2019s Abeta toxicity in human cerebral endothelial cells. Cell Mol Life Sci 66(6):1094\u20131104","journal-title":"Cell Mol Life Sci"},{"key":"8295_CR30","doi-asserted-by":"crossref","unstructured":"Nunes AF, Amaral JD, Lo AC, Fonseca MB, Viana RJ, Callaerts-Vegh Z, D\u2019Hooge R, Rodrigues CM (2012) TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-beta deposition in APP\/PS1 mice. Mol Neurobiol 45(3):440\u2013454","DOI":"10.1007\/s12035-012-8256-y"},{"issue":"4","key":"8295_CR31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00004647-200204000-00010","volume":"22","author":"CM Rodrigues","year":"2002","unstructured":"Rodrigues CM, Spellman SR, Sol\u00e1 S, Grande AW, Linehan-Stieers C, Low WC, Steer CJ (2002) Neuroprotection by a bile acid in an acute stroke model in the rat. J Cereb Blood Flow Metab 22(4):463\u2013471","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"8295_CR32","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1073\/pnas.1031632100","volume":"100","author":"CM Rodrigues","year":"2003","unstructured":"Rodrigues CM, Sola S, Nan Z, Castro RE, Ribeiro PS, Low WC, Steer CJ (2003) Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc Natl Acad Sci USA 100(10):6087\u20136092","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"8295_CR33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3727\/096020198389960","volume":"11","author":"WM Duan","year":"2002","unstructured":"Duan WM, Rodrigues CM, Zhao LR, Steer CJ, Low WC (2002) Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson\u2019s disease. Cell Transplant 11(3):195\u2013205","journal-title":"Cell Transplant"},{"issue":"52","key":"8295_CR34","doi-asserted-by":"crossref","first-page":"42655","DOI":"10.1074\/jbc.M505910200","volume":"280","author":"R Ved","year":"2005","unstructured":"Ved R, Saha S, Westlund B, Perier C, Burnam L, Sluder A, Hoener M, Rodrigues CM, Alfonso A, Steer C, Liu L, Przedborski S, Wolozin B (2005) Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J Biol Chem 280(52):42655\u201342668","journal-title":"J Biol Chem"},{"issue":"9","key":"8295_CR35","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1073\/pnas.95.9.5275","volume":"95","author":"CJ Henderson","year":"1998","unstructured":"Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR (1998) Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci USA 95(9):5275\u20135280","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"8295_CR36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12031-008-9141-z","volume":"38","author":"M Castro-Caldas","year":"2009","unstructured":"Castro-Caldas M, Neves Carvalho A, Peixeiro I, Rodrigues E, Lechner MC, Gama MJ (2009) GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL\/6 mouse midbrain and striatum. J Mol Neurosci 38(2):114\u2013127","journal-title":"J Mol Neurosci"},{"key":"8295_CR37","doi-asserted-by":"crossref","unstructured":"Kong XC, Zhang D, Qian C, Liu GT, Bao XQ (2011) FLZ, a novel HSP27 and HSP70 inducer, protects SH-SY5Y cells from apoptosis caused by MPP(+). Brain Res 1383:99\u2013107","DOI":"10.1016\/j.brainres.2011.01.093"},{"issue":"5","key":"8295_CR38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/02656730400023664","volume":"21","author":"DS Latchman","year":"2005","unstructured":"Latchman DS (2005) HSP27 and cell survival in neurones. Int J Hyperth 21(5):393\u2013402","journal-title":"Int J Hyperth"},{"issue":"2","key":"8295_CR39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1124\/jpet.104.070532","volume":"311","author":"RE Castro","year":"2004","unstructured":"Castro RE, Sol\u00e1 S, Ramalho RM, Steer CJ, Rodrigues CM (2004) The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons. J Pharmacol Exp Ther 311(2):845\u2013852","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"8295_CR40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC (2007) AKT\/PKB signaling: navigating downstream. Cell 129(7):1261\u20131274","journal-title":"Cell"},{"issue":"6748","key":"8295_CR41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/43474","volume":"401","author":"JA Romashkova","year":"1999","unstructured":"Romashkova JA, Makarov SS (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401(6748):86\u201390","journal-title":"Nature"},{"key":"8295_CR42","doi-asserted-by":"crossref","unstructured":"Kane LP, Shapiro VS, Stokoe D, Weiss A (1999) Induction of NF-kappaB by the Akt\/PKB kinase. Curr Biol 9(11):601\u2013604","DOI":"10.1016\/S0960-9822(99)80265-6"},{"key":"8295_CR43","doi-asserted-by":"crossref","unstructured":"Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG (1998) Parkinson\u2019s disease, pesticides, and glutathione transferase polymorphisms. Lancet 352(9137):1344\u20131346","DOI":"10.1016\/S0140-6736(98)03453-9"},{"key":"8295_CR44","doi-asserted-by":"crossref","unstructured":"Vilar R, Coelho H, Rodrigues E, Gama MJ, Rivera I, Taioli E, Lechner MC (2007) Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson\u2019s disease. Eur J Neurol 14(2):156\u2013161","DOI":"10.1111\/j.1468-1331.2006.01590.x"},{"key":"8295_CR45","doi-asserted-by":"crossref","unstructured":"Tsang AH, Chung KK (2009) Oxidative and nitrosative stress in Parkinson\u2019s disease. Biochim Biophys Acta 1792(7):643\u2013650","DOI":"10.1016\/j.bbadis.2008.12.006"},{"key":"8295_CR46","doi-asserted-by":"crossref","unstructured":"Stetler RA, Cao G, Gao Y, Zhang F, Wang S, Weng Z, Vosler P, Zhang L, Signore A, Graham SH, Chen J (2008) Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signaling. J Neurosci 28(49):13038\u201313055","DOI":"10.1523\/JNEUROSCI.4407-08.2008"},{"key":"8295_CR47","doi-asserted-by":"crossref","unstructured":"Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ, Ronai Z (1999) Regulation of JNK signaling by GSTp. EMBO J 18(5):1321\u20131334","DOI":"10.1093\/emboj\/18.5.1321"},{"issue":"25","key":"8295_CR48","doi-asserted-by":"crossref","first-page":"22243","DOI":"10.1074\/jbc.M301211200","volume":"278","author":"R Elsby","year":"2003","unstructured":"Elsby R, Kitteringham NR, Goldring CE, Lovatt CA, Chamberlain M, Henderson CJ, Wolf CR, Park BK (2003) Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi. J Biol Chem 278(25):22243\u201322249","journal-title":"J Biol Chem"},{"key":"8295_CR49","doi-asserted-by":"crossref","unstructured":"Yan LJ, Rajasekaran NS, Sathyanarayanan S, Benjamin IJ (2005) Mouse HSF1 disruption perturbs redox state and increases mitochondrial oxidative stress in kidney. Antioxid Redox Signal 7(3-4):465\u2013471","DOI":"10.1089\/ars.2005.7.465"},{"issue":"14","key":"8295_CR50","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0024-3205(94)00500-1","volume":"54","author":"K Kitani","year":"1994","unstructured":"Kitani K, Kanai S, Sato Y, Ohta M, Nokubo M (1994) Ursodeoxycholic acid reduces the systemic toxicity of 1,2-dichloro,4-nitrobenzene by stimulating hepatic glutathione S-transferase in mice. Life Sci 54(14):983\u2013989","journal-title":"Life Sci"},{"issue":"9","key":"8295_CR51","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.cellsig.2007.04.005","volume":"19","author":"XT Wang","year":"2007","unstructured":"Wang XT, Pei DS, Xu J, Guan QH, Sun YF, Liu XM, Zhang GY (2007) Opposing effects of Bad phosphorylation at two distinct sites by Akt1 and JNK1\/2 on ischemic brain injury. Cell Signal 19(9):1844\u20131856","journal-title":"Cell Signal"},{"key":"8295_CR52","doi-asserted-by":"crossref","unstructured":"del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687\u2013689","DOI":"10.1126\/science.278.5338.687"},{"key":"8295_CR53","doi-asserted-by":"crossref","unstructured":"Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231\u2013241","DOI":"10.1016\/S0092-8674(00)80405-5"},{"key":"8295_CR54","doi-asserted-by":"crossref","unstructured":"Parry GJ, Rodrigues CM, Aranha MM, Hilbert SJ, Davey C, Kelkar P, Low WC, Steer CJ (2010) Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic acid in patients with amyotrophic lateral sclerosis. Clin Neuropharmacol 33(1):17\u201321","DOI":"10.1097\/WNF.0b013e3181c47569"},{"key":"8295_CR55","doi-asserted-by":"crossref","unstructured":"Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ (1998) Measuring the rate of progression and estimating the preclinical period of Parkinson\u2019s disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry 64(3):314\u2013319","DOI":"10.1136\/jnnp.64.3.314"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-012-8295-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-012-8295-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-012-8295-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T17:46:18Z","timestamp":1561916778000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-012-8295-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,8]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["8295"],"URL":"https:\/\/doi.org\/10.1007\/s12035-012-8295-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,8]]}}}